OKOLICSANYI, STEFANO

OKOLICSANYI, STEFANO  

DIPARTIMENTO DI SCIENZE DELLA SALUTE (attivo dal 01/10/2012 al 30/09/2015)  

Mostra records
Risultati 1 - 20 di 40 (tempo di esecuzione: 0.029 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 01 - Articolo su rivista 2020 Strazzabosco M.Cortesi P. A.Conti S.Okolicsanyi S.Ciaccio A.Fornari C.Gemma M.Scalone L.Cesana G.Colledan M.Fagiuoli S.Mantovani L. G.Belli L. S. +
Health related quality of life in chronic liver diseases 01 - Articolo su rivista 2020 Paolo CortesiSara ContiLuciana ScaloneAntonio CiaccioStefano OkolicsanyiMatteo RotaMichele ColledanStefano FagiuoliGiancarlo CesanaMario StrazzaboscoLorenzo Mantovani +
Diagnostic Value of Quantitative Perfusion Computed Tomography Technique in the Assessment of Tumor Response to Sorafenib in Patients with Advanced Hepatocellular Carcinoma 01 - Articolo su rivista 2019 Ippolito, DavideQuerques, GiuliaPecorelli, AnnaTalei Franzesi, CammilloOkolicsanyi, StefanoStrazzabosco, MarioSironi, Sandro
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 02 - Intervento a convegno 2018 Fornari, CCortesi, PAConti, SOkolicsanyi, SRota, MCiaccio, AGemma, MScalone, LCesana, GColledan, MFagiuoli, SMantovani, LGStrazzabosco, M +
Dynamic contrast enhanced perfusion CT imaging: A diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions 01 - Articolo su rivista 2018 Ippolito, DavideQuerques, GiuliaOkolicsanyi, StefanoTalei Franzesi, CammilloPECORELLI, ANNALOMBARDI, SOPHIEORSINI, ELEONORA BENEDETTAStrazzabosco, MarioSironi, Sandro
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 02 - Intervento a convegno 2018 Conti SCortesi PAOkolicsanyi SRota MCiaccio AGemma MScalone LCesana GColledan MFagiuoli SMantovani LGStrazzabosco M +
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 01 - Articolo su rivista 2018 Carbone, MCristoferi, LCortesi, PARota, MCiaccio, AOkolicsanyi, SGemma, MScalone, LCesana, GColledan, MFagiuoli, SMantovani, LStrazzabosco, M +
Surgical management of hepatocellular carcinoma within and beyond BCLC indications in a middle volume center 01 - Articolo su rivista 2018 Garancini, M.Romano, F.Uggeri, F.Degrate, L.Okolicsanyi, S.Gianotti, L. +
Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: A feasibility study 01 - Articolo su rivista 2017 IPPOLITO, DAVIDEQUERQUES, GIULIAOKOLICSANYI, STEFANOSTRAZZABOSCO, MARIOSIRONI, SANDRO +
Difference in health related quality of life of chronic liver diseases and general population 01 - Articolo su rivista 2017 Cortesi, PAConti, SScalone, LCiaccio, AOkolicsanyi, SRota, MCesana, GStrazzabosco, MMantovani, LG +
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 01 - Articolo su rivista 2017 CIACCIO, ANTONIOCORTESI, PAOLO ANGELOBELLELLI, GIUSEPPEROTA, MATTEOCONTI, SARAOKOLICSANYI, STEFANOCESANA, GIANCARLOMantovani, LGANNONI, GIORGIOSTRAZZABOSCO, MARIO +
Impact of multidisciplinary team approach to liver tumors in a tertiary center: 5-years experience 01 - Articolo su rivista 2017 Okolicsanyi, S.Ciaccio, A.Romano, F.Uggeri, F.Vacirca, F.Mariani, A.Bovo, G.Invernizzi, P.Strazzabosco, M. +
Impact of multidisciplinary team approach to liver tumors: 5-Years experience 01 - Articolo su rivista 2017 OKOLICSANYI, STEFANOCIACCIO, ANTONIOROMANO, FABRIZIOUGGERI, FABIOVACIRCA, FRANCESCOMARIANI, CLAUDIO ANGELOSTRAZZABOSCO, MARIO +
Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured? 01 - Articolo su rivista 2017 OKOLICSANYI, STEFANOCIACCIO, ANTONIOSTRAZZABOSCO, MARIO +
Liver-allocation policies for patients affected by HCC in Europe 01 - Articolo su rivista 2016 DE CARLIS, LUCIANO GREGORIOLauterio, AOKOLICSANYI, STEFANOBelli, LSTRAZZABOSCO, MARIO +
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 01 - Articolo su rivista 2015 CIACCIO, ANTONIOOKOLICSANYI, STEFANOROTA, MATTEOCORTESI, PAOLO ANGELOGEMMA, MARTAMANTOVANI, LORENZO GIOVANNISTRAZZABOSCO, MARIO +
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 01 - Articolo su rivista 2015 Cortesi, PCiaccio, ARota, MOkolicsanyi, SMantovani, LStrazzabosco, M +
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 01 - Articolo su rivista 2015 CIACCIO, ANTONIOOKOLICSANYI, STEFANOROTA, MATTEOCORTESI, PAOLO ANGELOFagiuoli, SSCALONE, LUCIANACESANA, GIANCARLOMANTOVANI, LORENZO GIOVANNISTRAZZABOSCO, MARIO +
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 01 - Articolo su rivista 2015 CIACCIO, ANTONIOOKOLICSANYI, STEFANOROTA, MATTEOCORTESI, PAOLO ANGELOGEMMA, MARTAFagiuoli, SSCALONE, LUCIANAVALSECCHI, MARIA GRAZIAMANTOVANI, LORENZO GIOVANNISTRAZZABOSCO, MARIO +
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 01 - Articolo su rivista 2015 CIACCIO, ANTONIOCORTESI, PAOLO ANGELOBELLELLI, GIUSEPPEROTA, MATTEOOKOLICSANYI, STEFANOMANTOVANI, LORENZO GIOVANNIANNONI, GIORGIOSTRAZZABOSCO, MARIO +